|
FOCUS ON FACILITIES DESIGN |
|
|
|
A conversation with Eamonn Warren, Eli Lilly and Company | If the disruption of implementing and adapting to new technology costs more than its benefits, teams should proceed cautiously. | |
|
|
| Refurbishing Single-Use Systems To Drive Sustainability | Case Study | Single Use Support | How can biopharma reduce its environmental footprint? Discover a refurbishment model that transforms single-use components into a multi-use system, significantly cutting down on disposable plastic waste. |
|
|
| The Modular Advantage: Stick Built Vs. Modular | Article | By Royce Tourtillott, AES Cleanroom Technology | There are three major options when building a pharmaceutical grade cleanroom on your existing site — stick built, modular, or podular. Here, modular installation and stick built construction are compared. |
|
|
|
|
FACILITIES DESIGN SOLUTIONS |
|
|
|
|
|
|
|
| The 4th mRNA Process Development & CMC Summit returns to Boston (September 23-25) as the world’s only flagship forum dedicated to overcoming bottlenecks and help mRNA therapeutic and vaccine developers deliver safer and more effective mRNA drugs to patients. Featuring insights from Sanofi, GSK, Moderna, AstraZeneca, CSL, BioNTech, CEPI, US Pharmacopeia, CureVac, Editas Medicines, and many more! |
|
|
FOCUS ON MANUFACTURING CONTROLS |
|
|
|
| Driving Digital Excellence In Life Sciences | White Paper | Emerson | The life sciences industry is rapidly evolving through digital transformation and agility. Discover why embracing modern technologies is essential to thrive in today’s competitive landscape. |
|
|
|
|
| Can Today's ELNs Support Tomorrow's Labs? | Article | By Stuart Ward, IDBS | The global electronic laboratory notebook (ELN) market is growing, however, ELNs must form part of a more comprehensive data strategy and ecosystem or they can impede progress. |
|
|
|
| Developing New Medicines Through Artificial Intelligence | Article | By Tony Reina, Resilience US, Inc. | Embrace the future of drug development by leveraging AI and innovative protein synthesis technologies to accelerate the creation of effective therapies and transform patient outcomes. |
|
|
|
|
|
| Revolutionizing Pharma Validation With AI | Article | Aizon | Validation in GxP environments is often the bottleneck in digital transformation—manual, repetitive, and complex. One company's Intelligent Agents are transforming that process. |
|
|
|
|
MANUFACTURING CONTROLS SOLUTIONS |
|
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|